94 related articles for article (PubMed ID: 3261801)
1. Macrophage infiltration into experimental brain metastases: occurrence through an intact blood-brain barrier.
Schackert G; Simmons RD; Buzbee TM; Hume DA; Fidler IJ
J Natl Cancer Inst; 1988 Sep; 80(13):1027-34. PubMed ID: 3261801
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical analysis of the involvement of F4/80 and Ia-positive macrophages in mouse liver infected with lymphocytic choriomeningitis virus.
Dixon JE; Allan JE; Doherty PC; Hume DA
J Leukoc Biol; 1986 Nov; 40(5):617-28. PubMed ID: 3464677
[TBL] [Abstract][Full Text] [Related]
3. Site-specific immune response to implanted gliomas.
Proescholdt MA; Merrill MJ; Ikejiri B; Walbridge S; Akbasak A; Jacobson S; Oldfield EH
J Neurosurg; 2001 Dec; 95(6):1012-9. PubMed ID: 11765816
[TBL] [Abstract][Full Text] [Related]
4. Rejection of K1735 murine melanoma in syngeneic hosts requires expression of MHC class I antigens and either class II antigens or IL-2.
Chen PW; Ananthaswamy HN
J Immunol; 1993 Jul; 151(1):244-55. PubMed ID: 8326126
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory cell infiltrates vary in experimental primary and metastatic brain tumors.
Morioka T; Baba T; Black KL; Streit WJ
Neurosurgery; 1992 Jun; 30(6):891-6. PubMed ID: 1614593
[TBL] [Abstract][Full Text] [Related]
6. Enriched immune-environment of blood-brain barrier deficient areas of normal adult rats.
Pedersen EB; McNulty JA; Castro AJ; Fox LM; Zimmer J; Finsen B
J Neuroimmunol; 1997 Jun; 76(1-2):117-31. PubMed ID: 9184641
[TBL] [Abstract][Full Text] [Related]
7. Differential permeability of the blood-brain barrier in experimental brain metastases produced by human neoplasms implanted into nude mice.
Zhang RD; Price JE; Fujimaki T; Bucana CD; Fidler IJ
Am J Pathol; 1992 Nov; 141(5):1115-24. PubMed ID: 1443046
[TBL] [Abstract][Full Text] [Related]
8. Expression of major histocompatibility complex antigens and induction of human T-lymphocyte proliferation by astrocytes and macrophages from porcine fetal brain.
Brevig T; Kristensen T; Zimmer J
Exp Neurol; 1999 Oct; 159(2):474-83. PubMed ID: 10506518
[TBL] [Abstract][Full Text] [Related]
9. Antigen presentation in the central nervous system. The inhibitory effect of IL-10 on MHC class II expression and production of cytokines depends on the inducing signals and the type of cell analyzed.
Frei K; Lins H; Schwerdel C; Fontana A
J Immunol; 1994 Mar; 152(6):2720-8. PubMed ID: 8144879
[TBL] [Abstract][Full Text] [Related]
10. Induction of interleukin 1 alpha mRNA during the antigen-dependent interaction of sensitized T lymphoblasts with macrophages.
Koide S; Steinman RM
J Exp Med; 1988 Jul; 168(1):409-16. PubMed ID: 2969406
[TBL] [Abstract][Full Text] [Related]
11. Fibrosarcoma cells expressing allogeneic MHC Class II antigens induce protective antitumor immunity.
Leach DR; Callahan GN
J Immunol; 1995 Jan; 154(2):738-43. PubMed ID: 7814880
[TBL] [Abstract][Full Text] [Related]
12. Protective antitumor immunity induced by immunization with MHC class II gene-transfected tumor cells is unrelated to MHC class II expression.
Leach DR; Callahan GN
Pathobiology; 1995; 63(2):57-64. PubMed ID: 8554700
[TBL] [Abstract][Full Text] [Related]
13. Diversity in phenotype and steroid hormone dependence in dendritic cells and macrophages in the mouse uterus.
Keenihan SN; Robertson SA
Biol Reprod; 2004 Jun; 70(6):1562-72. PubMed ID: 14766730
[TBL] [Abstract][Full Text] [Related]
14. Active specific immunotherapy against occult brain metastasis.
Lu W; Su J; Kim LS; Bucana CD; Donawho C; He J; Fidler IJ; Dong Z
Cancer Res; 2003 Mar; 63(6):1345-50. PubMed ID: 12649197
[TBL] [Abstract][Full Text] [Related]
15. Mycoplasma fermentans-derived lipid inhibits class II major histocompatibility complex expression without mediation by interleukin-6, interleukin-10, tumor necrosis factor, transforming growth factor-beta, type I interferon, prostaglandins or nitric oxide.
Frisch M; Gradehandt G; Mühlradt PF
Eur J Immunol; 1996 May; 26(5):1050-7. PubMed ID: 8647166
[TBL] [Abstract][Full Text] [Related]
16. In situ augmentation of class I major histocompatibility antigen expression on immunogenic variants of a spontaneous murine mammary carcinoma.
Elliott BE; Carlow DA; Ivimey L; Arnold M; Hampton N; Bosman P
Cancer Res; 1987 Sep; 47(18):4915-23. PubMed ID: 2441856
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical analysis of murine mononuclear phagocytes that express class II major histocompatibility antigens.
Hume DA
Immunobiology; 1985 Dec; 170(5):381-9. PubMed ID: 3867611
[TBL] [Abstract][Full Text] [Related]
18. Lymphokine-independent induction of macrophage membrane IL-1 by autoreactive T cells recognizing either class I or class II MHC determinants.
Wasik MA; Donnelly RP; Beller DI
J Immunol; 1988 Nov; 141(10):3456-62. PubMed ID: 2460535
[TBL] [Abstract][Full Text] [Related]
19. Tumour-specific CTL response requiring interactions of four different cell types and recognition of MHC class I and class II restricted tumour antigens.
Schirrmacher V; Schild HJ; Gückel B; von Hoegen P
Immunol Cell Biol; 1993 Aug; 71 ( Pt 4)():311-26. PubMed ID: 7901150
[TBL] [Abstract][Full Text] [Related]
20. Expression of major histocompatibility complex molecules in rodent retina. Immunohistochemical study.
Zhang J; Wu GS; Ishimoto S; Pararajasegaram G; Rao NA
Invest Ophthalmol Vis Sci; 1997 Aug; 38(9):1848-57. PubMed ID: 9286275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
